Syria will increase the production capacity of pharmaceutical companies in terms of sanctions
In the face of increasing sanctions pressure on the health sector in Syria, state-owned pharmaceutical company will expand production of alternative export analogues of drugs to prevent shortages, said in an interview with RIA Novosti Deputy Minister of health of the Syrian Ahmad Lafave.
The Deputy Minister noted that the plants in Syria for the production of drugs provide most of the needs of the domestic market. The Ministry of health has expanded the list of approved alternative medicinal components to increase options to ensure and to prevent deficit.
"Agreement in the medical field have already been achieved with several friendly countries, including Korea and Iran. The Ministry is now preparing to sign a cooperation agreement with other countries, such as India," added Lafave.
Foreign Minister of Syria Walid Muallem said that the US is trying to deprive the Syrian population, "the last piece of bread," using sanctions as a last weapon to achieve their goals in Syria. According to him, Damascus has learned to resist sanctions Washington and take action to counter the effects of sanctions.